However, the expression of DLGAP4 was not significantly associated with other clinical features, including age, height, race, surrounding liver tissue inflammation, vascular invasion, tumour status, residual tumour and progression-free interval (PFI) (see Supplementary Fig. 1A–H). The gene discussed is DLGAP4; the disease is neoplasm.